US on target ‘to reach a vaccine by year’s end or early next year’: Official

Small bottles labeled with "Vaccine"stickers stand near a medical syringe in front of displayed "Coronavirus COVID-19"words in this illustration taken April 10, 2020. Reuters. Sketched by the Pan Pacific Agency.

WASHINGTON D.C., Jul 2, 2020, CNN. The United States remains on target to have a Covid-19 vaccine available by the end of the year or early next year, US Food and Drug Administration Commissioner Dr. Stephen Hahn said on Thursday, CNN reported.

“FDA has given authorization to proceed with clinical trials for four separate vaccines and we’ve seen a number of vaccine developers come forward — double digit numbers — so we have a lot of different, if you will, shots on goal with respect to vaccines. That’s good news,” Hahn told ABC’s Whit Johnson during an appearance on Good Morning America.

Cautiously optimistic: “We expect two of these vaccines to go in the late stage of clinical trials, which are large clinical trials, in this month,” Hahn said. “We are on target to reach a vaccine by year’s end or early next year, so I’m cautiously optimistic. Of course it depends upon the data that are generated from the trial.”

Hahn added that FDA’s job is to assess the data and science from the trials to determine the safety and efficacy of that vaccine. According to the World Health Organization, there are 17 candidate vaccines in clinical evaluation globally.

Share it

Exclusive: Beyond the Covid-19 world's coverage